Skip to main content
Segalés, J., Sánchez-Martín, C., Pujol-Morcillo, A., Martíon-Ruiz,M., de los Santos, P., Lobato-Alonso, D., Oliver, E., Rial, E.
[2023]. Role of UCP2 in the Energy Metabolism of the Cancer Cell Line A549. International Journal of Molecular Sciences. 24:8123.
Abengózar, M.A., Fernández-Reyes, M., Salazar, V.A., Torrent, M., de la Torre, B.G., Andreu, D., Boix, E., Rivas, L.
[2022]. Essential role of enzymatic activity in the Leishmanicidal mechanism of the eosinophil cationic protein (RNase 3). ACS Infectious Diseases. 8:1207-1217.
Lima, M.L., Abengózar, M.A., Torres-Santos, E.C., Borborema, S.E.T., Godzien, J., López-Gonzálvez, Á., Barbas, C., Rivas, L., Tempone, A.G.
[2022]. Energy metabolism as a target for cyclobenzaprine: A drug candidate against visceral Leishmaniasis. Bioorganic Chemistry. 127:106009
Sebastián-Pérez, V., Martínez de Iturrate, P., Nácher-Vázquez, M., Nóvoa, L., Pérezm, C., Campillo, N.E., Gil, C., Rivas, L.
[2022]. Naphthoquinone as a New Chemical Scaffold for Leishmanicidal Inhibitors of Leishmania GSK-3. Biomedicines. 10:1136.
Pérez-Liébana, I., Juaristi, I., González-Sánchez, P., González-Moreno, L., Rial, E., Podunavac, M., Zakarian, A., Molgó, J., Vallejo-Illarramendi, A., Mosqueira-Martín, L., Lopez de Munain, A., Pardo, B., Satrústegui, J., Del Arco, A.
[2022]. A Ca2+-dependent mechanism boosting glycolysis and OXPHOS by activating aralar-malate-aspartate shuttle, upon neuronal stimulation. Journal of Neuroscience. 42:3879-3895.
Illa, O., Olivares, J.-A., Gaztelumendi, N., Martínez-Castro, L., Ospina, J., Abengozar, M.-Á., Sciortino, G., Maréchal, J.-D., Nogués, C., Royo, M., Rivas, L., Ortuño, R.M.
[2020]. Chiral cyclobutane-containing cell-penetrating peptides as selective vectors for anti-leishmania drug delivery systems. International Journal of Molecular Sciences. 21:1-24.
Aguado, T., García, M., García, A., Ferrer-Mayorga, G., Martínez-Santamaría, L., Del Río, M., Botella, L.-M., Sánchez-Puelles, J.-M.
[2020]. Raloxifene and n-Acetylcysteine Ameliorate TGF-Signalling in Fibroblasts from Patients with Recessive Dominant Epidermolysis Bullosa. Cells. 9:-.
González, L.A., Upegui, Y.A., Rivas, L., Echeverri, F., Escobar, G., Robledo, S.M., Quiñones, W.
[2020]. Effect of substituents in the A and B rings of chalcones on antiparasite activity. Archiv der Pharmazie.(In press) :-.
Martínez de Iturrate, P., Sebastián-Pérez, V., Nácher-Vázquez, M., Tremper, C.S., Smirlis, D., Martín, J., Martínez, A., Campillo, N.E., Rivas, L., Gil, C.
[2020]. Towards discovery of new leishmanicidal scaffolds able to inhibit Leishmania GSK-3. Journal of Enzyme Inhibition and Medicinal Chemistry. 35:199-210.
Hendrickx, S., Van Bockstal, L., Bulté, D., Mondelaers, A., Aslan, H., Rivas, L., Maes, L., Caljon, G.
[2020]. Phenotypic adaptations of Leishmania donovani to recurrent miltefosine exposure and impact on sand fly infection. Parasites and Vectors. 13:Article 96
Almalé, L., García-Álvaro, M., Martínez-Palacián, A., García-Bravo, M., Lazcanoiturburu, N., Addante, A., Roncero, C., Sanz, J., de la O López, M., Bragado, P., Mikulits, W., Factor, V.M., Thorgeirsson, S.S., Casal, J.I., Segovia, J.-C., Rial, E., Fabregat, I., Herrera, B., Sánchez, A.
[2019]. c-Met Signaling Is Essential for Mouse Adult Liver Progenitor Cells Expansion After Transforming Growth Factor-β-Induced Epithelial–Mesenchymal Transition and Regulates Cell Phenotypic Switch. Stem Cells. 37:1108-1118.
Carregal, V.M., Lanza, J.S., Souza, D.M., Islam, A., Demicheli, C., Fujiwara, R.T., Rivas, L., Frézard, F.
[2019]. Combination oral therapy against Leishmania amazonensis infection in BALB/c mice using nanoassemblies made from amphiphilic antimony(V) complex incorporating miltefosine. Parasitology Research. 118:3077-3084.
Staderini, M., Piquero, M., Abengózar, M.Á., Nachér-Vázquez, M., Romanelli, G., López-Alvarado, P., Rivas, L., Bolognesi, M.L., Menéndez, J.C.
[2019]. Structure-activity relationships and mechanistic studies of novel mitochondria-targeted, leishmanicidal derivatives of the 4-aminostyrylquinoline scaffold. European Journal of Medicinal Chemistry. 171:38-53.
Carregal, V.M., Lanza, J.S., Souza, D.M., Islam, A., Demicheli, C., Fujiwara, R.T., Rivas, L., Frézard, F.
[2019]. Combination oral therapy against Leishmania amazonensis infection in BALB/c mice using nanoassemblies made from amphiphilic antimony(V) complex incorporating miltefosine. Parasitology Research. 118:3077-3084.
Arsène, S., Gómez-Pérez, V., Escarcena, R., Abengózar, M.Á., García-Hernández, R., Nácher-Vázquez, M., San Feliciano, A., Gamarro, F., Rivas, L., Olmo, E.D.
[2019]. Imidazo[2,1-a]isoindole scaffold as an uncharted structure active on Leishmania donovani. European Journal of Medicinal Chemistry. 182:article 11568-.
Aguado, T., Romero-Revilla, J.A., Granados, R., Campuzano, S., Torrente-Rodríguez, R.M., Cuesta, Á.M., Albiñana, V., Botella, L.M., Santamaría, S., Garcia-Sanz, J.A., Pingarrón, J.M., Sánchez-Sancho, F., Sánchez-Puelles, J.-M.
[2019]. 11PS04 is a new chemical entity identified by microRNA-based biosensing with promising therapeutic potential against cancer stem cells. Scientific Reports. 9: Article 11916